Mar 28, 2024 GenomeWeb: Castle Biosciences Squamous Cell Cancer Test Utility Boosted by New Validation Data, Expert Opinion
Mar 25, 2024 Clinical Trials Arena: Castle Biosciences Reveals Melanoma Test Study Findings at SSO 2024
Mar 22, 2024 The Dermatology Digest: New Data Supports the Role of Castle’s DecisionDx-Melanoma GEP Test for Assessing the Need for SLN Biopsies
Feb 28, 2024 Practical Dermatology: Study: Test Improves the Risk Stratification of Patients with Stage I Melanoma
Feb 1, 2024 American Journal of Managed Care: 40-GEP Test Utilization Can Mitigate Financial Burden of Cutaneous Squamous Cell Carcinoma
